Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/2/2025

Safe Use of Amitriptyline and Trazodone

Introduction to Safety Concerns

  • The American Geriatrics Society recommends avoiding the combination of amitriptyline and trazodone in elderly patients due to increased risk of adverse effects, particularly falls, cognitive impairment, and daytime dysfunction 1

Clinical Management

  • The American Geriatrics Society suggests that if the combination of amitriptyline and trazodone cannot be avoided, doses should be initiated at the lowest possible levels: amitriptyline 10-25 mg/day and trazodone 25-50 mg/day, with slow increases and close monitoring for adverse effects 1
  • The American Diabetes Association, as reported in Diabetes/Metabolism Research and Reviews, advises considering alternative medications like duloxetine for neuropathic pain, which has better tolerability than tricyclics and avoids interaction risks 2

Safer Alternatives for Treatment

  • The American Gastroenterological Association, as reported in Clinical Gastroenterology and Hepatology, recommends considering gabapentin or pregabalin as effective alternatives for neuropathic pain without serotonergic effects 4
  • The American Geriatrics Society suggests using a single agent at an optimized dose rather than combining two sedating antidepressants for depression with insomnia, and considering mirtazapine as a single agent that provides both antidepressant and sedative effects without interaction risk 1

Discontinuation and Monitoring

  • The American Geriatrics Society advises against abrupt discontinuation of either medication if the combination must be stopped, recommending instead a tapering of doses to avoid discontinuation syndrome 1